These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1362781)
1. [Polymorphism of T cell receptor genes and hyper-production of cytokines: their possible contribution to the pathogenesis of IgA nephropathy in ddY mouse]. Nagasawa R; Takahashi T; Mitarai T Nihon Rinsho; 1992 Dec; 50(12):3051-5. PubMed ID: 1362781 [TBL] [Abstract][Full Text] [Related]
2. IgA nephropathy: lessons from an animal model, the ddY mouse. Tomino Y J Nephrol; 2008; 21(4):463-7. PubMed ID: 18651534 [TBL] [Abstract][Full Text] [Related]
3. Detection of antioxidant enzyme activities in renal tissues of early stage IgA nephropathy in ddY mice. Wang LN; Fukui M; Shou I; Yaguchi Y; Funabiki K; Horikoshi S; Shirato I; Tomino Y J Clin Lab Anal; 1996; 10(6):394-8. PubMed ID: 8951608 [TBL] [Abstract][Full Text] [Related]
4. Evidence suggesting the involvement of hematopoietic stem cells in the pathogenesis of IgA nephropathy. Imasawa T; Utsunomiya Y; Kawamura T; Nagasawa R; Maruyama N; Sakai O Biochem Biophys Res Commun; 1998 Aug; 249(3):605-11. PubMed ID: 9731183 [TBL] [Abstract][Full Text] [Related]
5. Neonatal thymectomy diminishes renal IgA deposition in IgA nephropathy-prone ddY mice. Nagasawa R; Mitarai T; Utsunomiya Y; Yoshida H; Kitamura M; Yamura W; Maruyama N; Isoda K; Sakai O Nephron; 1994; 66(3):326-32. PubMed ID: 8190186 [TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of IgA nephropathy. Feehally J; Allen AC Ann Med Interne (Paris); 1999 Feb; 150(2):91-8. PubMed ID: 10392257 [TBL] [Abstract][Full Text] [Related]
7. [Pathogenesis and therapy of IgA nephropathy]. Sakai O Nihon Jinzo Gakkai Shi; 1994 Jun; 36(6):683-91. PubMed ID: 8084068 [TBL] [Abstract][Full Text] [Related]
8. Structural features of IgA molecules which contribute to IgA nephropathy. Feehally J; Allen AC J Nephrol; 1999; 12(2):59-65. PubMed ID: 10378660 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein-1 levels are increased in patients with IgA nephropathy. Tokunaga K; Uto H; Takami Y; Mera K; Nishida C; Yoshimine Y; Fukumoto M; Oku M; Sogabe A; Nosaki T; Moriuchi A; Oketani M; Ido A; Tsubouchi H Biochem Biophys Res Commun; 2010 Aug; 399(2):144-9. PubMed ID: 20637724 [TBL] [Abstract][Full Text] [Related]
10. Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23. Suzuki H; Suzuki Y; Yamanaka T; Hirose S; Nishimura H; Toei J; Horikoshi S; Tomino Y J Am Soc Nephrol; 2005 May; 16(5):1289-99. PubMed ID: 15772254 [TBL] [Abstract][Full Text] [Related]
11. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753 [TBL] [Abstract][Full Text] [Related]
12. Evidence for genetic factors in the development and progression of IgA nephropathy. Hsu SI; Ramirez SB; Winn MP; Bonventre JV; Owen WF Kidney Int; 2000 May; 57(5):1818-35. PubMed ID: 10792601 [TBL] [Abstract][Full Text] [Related]
13. Injection of recombinant FcalphaRI/CD89 in mice does not induce mesangial IgA deposition. van der Boog PJ; van Kooten C; van Zandbergen G; Klar-Mohamad N; Oortwijn B; Bos NA; van Remoortere A; Hokke CH; de Fijter JW; Daha MR Nephrol Dial Transplant; 2004 Nov; 19(11):2729-36. PubMed ID: 15340093 [TBL] [Abstract][Full Text] [Related]
14. [Progress in understanding the pathogenesis of IgA nephropathy: new perspectives for the near future?]. Segarra A Nefrologia; 2010; 30(5):501-7. PubMed ID: 20882091 [TBL] [Abstract][Full Text] [Related]
15. Role of intercellular adhesion molecule-1, lymphocyte function-associated antigen-1, and macrophages in ddY mouse nephropathy. Ye XF; Yorioka N; Oda H; Taniguchi Y; Yamakido M Hiroshima J Med Sci; 1997 Jun; 46(2):75-80. PubMed ID: 9232935 [TBL] [Abstract][Full Text] [Related]
16. Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation. Coppo R; Amore A; Chiesa M; Lombardo F; Cirina P; Andrulli S; Passerini P; Conti G; Peruzzi L; Giraudi R; Messina M; Segoloni G; Ponticelli C Clin Transplant; 2007; 21(6):728-37. PubMed ID: 17988266 [TBL] [Abstract][Full Text] [Related]
17. CD4-positive cells from patients with IgA nephropathy demonstrate increased mRNA of cytokines that induce the IgA switch and differentiation. Lai KN; Ho RT; Leung JC; Chui YL; Lim PL; Lui SF; Li PK J Pathol; 1994 Sep; 174(1):13-22. PubMed ID: 7965399 [TBL] [Abstract][Full Text] [Related]
18. [Polymorphism of immunoglobulin heavy chain switch region in IgA nephropathy]. Miyazaki M; Sakai H Nihon Rinsho; 1992 Dec; 50(12):3046-50. PubMed ID: 1491458 [TBL] [Abstract][Full Text] [Related]
19. Increase in B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy. Goto T; Bandoh N; Yoshizaki T; Nozawa H; Takahara M; Ueda S; Hayashi T; Harabuchi Y Clin Immunol; 2008 Mar; 126(3):260-9. PubMed ID: 18249037 [TBL] [Abstract][Full Text] [Related]
20. IgA deposits might not influence the production of extracellular matrix in glomeruli of ddY mice, a spontaneous animal model for IgA nephropathy. Tsushima Y; Tomino Y; Shimizu M; Ohmuro H; Takeuchi K; Kuramoto T; Shirato I; Koide H Nephron; 1994; 66(1):81-6. PubMed ID: 7906404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]